Submitted by Anonymous (not verified) on 26 October 2023 - 10:59
Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Diabetes Mellitus, Type 2, Date of authorisation: 15/09/2022, Revision: 3, Status: Authorised
Source: